drugset / Trial / NCT00002336

The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

NCT00002336

Completed Abbott
Double-blindTreatment

Summary

To determine whether clarithromycin is safe and effective in preventing disseminated Mycobacterium avium Complex in HIV-infected patients with CD4 counts \<= 100 cells/mm3.

Timeline

Start
1992-11
Primary completion
1994-11
Completion
1994-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Clarithromycin Small molecule